VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Vaccine Mechanisms
Vaximmutordb
Vaxism
Vaxar
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UMMS Logo

Vaccine Detail

Prevnar 13
Vaccine Information
  • Vaccine Name: Prevnar 13
  • Target Pathogen: Streptococcus pneumoniae
  • Target Disease: Pneumonia
  • Product Name: Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]
  • Tradename: Prevnar
  • Manufacturer: Wyeth Pharmaceuticals, Inc
  • Vaccine Ontology ID: VO_0001244
  • CDC CVX code: 133
  • Type: Conjugate vaccine
  • Status: Licensed
  • Location Licensed: USA, Canada
  • Host Species for Licensed Use: Human
  • Adjuvant: aluminum phosphate vaccine adjuvant
  • Immunization Route: Intramuscular injection (i.m.)
  • Storage: Store refrigerated at +2ºC to +8ºC (36ºF to 46ºF)
  • Approved Age for Licensed Use: Children 6 weeks through 5 years of age (FDA: Prevnar 13).
Host Response
References
FDA: Prevnar 13: FDA: Prevnar 13 [http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm201667.htm]